Halozyme Therapeutics has expanded its portfolio of drug delivery technologies for a second time in a few months with the acquisition of Surf Bio and its subcutaneous injection platform. The ...
Does this evidence actually point to a long-lost “medieval New York”?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results